Cyclopropyl Amine Derivatives for Selective H3 Receptor Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for conditions related to histamine-3 (H3) receptor modulation, such as memory and cognition disorders, lack effective compounds that can selectively modulate H3 receptor activity for therapeutic benefits.
Innovation Solution
Development of cyclopropyl amine derivatives, including bicyclic and tricyclic substituted cyclopropyl amine compounds, which can be used in pharmaceutical compositions to selectively modulate H3 receptor activity, thereby treating or preventing related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional H3 receptor ligands are used, then H3 receptor modulation activity is achieved, but selectivity and therapeutic efficacy are insufficient
Solution Approach 1:
The patent applies local quality by introducing specific substituents at defined positions on the cyclopropyl amine core structure. Different substituents (R1-R6) are placed at specific locations to optimize both H3 receptor binding affinity and selectivity, allowing the molecule to interact preferentially with H3 receptors over other histamine receptors
Solution Approach 2:
The patent employs parameter changes by systematically varying chemical parameters such as substituent types, ring sizes, and molecular weight within the cyclopropyl amine framework. This allows optimization of the balance between receptor selectivity and therapeutic efficacy by adjusting molecular properties
2Adaptability or versatility
If complex multi-substituted cyclopropyl amine structures are developed, then H3 receptor selectivity is improved, but synthesis complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the complex cyclopropyl amine molecule into modular components (core cyclopropyl amine structure plus various substituent groups R1-R6). This modular approach allows systematic synthesis where different substituent modules can be independently prepared and then assembled onto the core structure, reducing overall synthesis complexity
Solution Approach 2:
The patent employs universality by designing a core cyclopropyl amine structure that serves multiple functions: providing the essential H3 receptor binding motif while allowing attachment of various substituents to achieve different selectivity profiles. This universal core simplifies synthesis compared to developing entirely different molecular frameworks for each compound
Data Source
AI summary
Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).